Study details
Enrolling now
CyberKnife Radiosurgery for Kidney Cancer
Beth Israel Deaconess Medical Center
NCT IDNCT01890590ClinicalTrials.gov data as of Apr 2026
Target enrollment
46
Study length
about 12 years
Ages
18+
Locations
1 site in MA
What this study is about
This trial is testing CyberKnife radiosurgery as a way to treat kidney cancer. The goal is to evaluate if CyberKnife can be used effectively for treating kidney cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use CyberKnife
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: To determine impact of therapy on quality of life., To evaluate adverse events.
Body systems
Oncology